JP2001517698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001517698A5 JP2001517698A5 JP2000513573A JP2000513573A JP2001517698A5 JP 2001517698 A5 JP2001517698 A5 JP 2001517698A5 JP 2000513573 A JP2000513573 A JP 2000513573A JP 2000513573 A JP2000513573 A JP 2000513573A JP 2001517698 A5 JP2001517698 A5 JP 2001517698A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97A000586 | 1997-09-30 | ||
IT97RM000586A IT1295405B1 (it) | 1997-09-30 | 1997-09-30 | Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di |
PCT/IT1998/000259 WO1999016437A1 (en) | 1997-09-30 | 1998-09-30 | Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001517698A JP2001517698A (ja) | 2001-10-09 |
JP2001517698A5 true JP2001517698A5 (ja) | 2005-12-22 |
Family
ID=11405271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000513573A Pending JP2001517698A (ja) | 1997-09-30 | 1998-09-30 | 腎移植患者の生存率を増大させる薬剤の製造のためのアンギオテンシンii受容体アンタゴニストの使用 |
Country Status (12)
Country | Link |
---|---|
US (1) | US6576652B2 (ja) |
EP (1) | EP1019048B1 (ja) |
JP (1) | JP2001517698A (ja) |
AT (1) | ATE258051T1 (ja) |
AU (1) | AU754852B2 (ja) |
CA (1) | CA2303217C (ja) |
DE (1) | DE69821252T2 (ja) |
DK (1) | DK1019048T3 (ja) |
ES (1) | ES2213296T3 (ja) |
IT (1) | IT1295405B1 (ja) |
PT (1) | PT1019048E (ja) |
WO (1) | WO1999016437A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638937B2 (en) | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
BR0102252B1 (pt) | 2001-04-10 | 2013-10-22 | Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso | |
CA2482857A1 (en) | 2002-04-29 | 2003-11-13 | Teva Pharmaceutical Industries Ltd. | Processes for preparing losartan and losartan potassium |
WO2005097109A1 (en) * | 2004-04-01 | 2005-10-20 | Daniel Batlle | Methods for achieving a protective ace2 expression level |
US20050282877A1 (en) * | 2004-04-13 | 2005-12-22 | Becker Bryan N | Method of decreasing inflammation in kidney transplantion using angiotensin receptor blockers |
US7531560B2 (en) * | 2004-11-10 | 2009-05-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
CA2760031C (en) * | 2009-04-28 | 2015-03-10 | Daiichi Sankyo Company, Limited | Acetone solvate crystals of trityl olmesartan medoxomil |
NO2944633T3 (ja) * | 2012-11-14 | 2018-06-30 | ||
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
US20210105999A1 (en) * | 2018-03-29 | 2021-04-15 | Bruno Reichart | Compositions for prolonging the survival after orthotopic and heterotopic xenogeneic heart, kidney, lung or liver transplantations |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH528514A (de) | 1969-05-22 | 1972-09-30 | Bayer Ag | Verfahren zur Herstellung von Acylimidazolen |
JPS54148788A (en) | 1978-05-15 | 1979-11-21 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation |
JPS55313A (en) | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
DK531479A (da) | 1979-01-19 | 1980-07-20 | Pfizer | Fremgangsmaade til fremstilling af imidazolderivater og salte deraf |
JPS5671073A (en) | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | Imidazole derivative |
JPS5671074A (en) | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
DE3106150A1 (de) | 1981-02-13 | 1982-09-16 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "verfahren zur herstellung von imidazolessigsaeurederivaten" |
JPS58157768A (ja) | 1982-03-16 | 1983-09-19 | Takeda Chem Ind Ltd | 4−クロロ−2−フエニルイミダゾ−ル−5−酢酸誘導体 |
PT78388B (en) | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
FI833794A0 (fi) | 1983-10-18 | 1983-10-18 | Farmos Oy | Substituerade 2-merkapto-imidazoler |
US5138069A (en) | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
US5064825A (en) * | 1989-06-01 | 1991-11-12 | Merck & Co., Inc. | Angiotensin ii antagonists |
EP0505098A1 (en) * | 1991-03-19 | 1992-09-23 | Merck & Co. Inc. | Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists |
US5492904A (en) * | 1991-05-15 | 1996-02-20 | E. I. Du Pont De Nemours And Company | Composition of angiotensin-II receptor antagonists and calcium channel blockers |
KR100212257B1 (ko) | 1991-11-18 | 1999-08-02 | 미리암 디. 메코나헤이 | Aii 수용체 길항물질을 합성하기 위한 테트라졸릴페닐보론산 중간체의 제조 방법 |
US5130439A (en) | 1991-11-18 | 1992-07-14 | Lo Young S | Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists |
US5219856A (en) * | 1992-04-06 | 1993-06-15 | E. I. Du Pont De Nemours And Company | Angiotensin-II receptor blocking, heterocycle substituted imidazoles |
US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
US5395844A (en) * | 1993-06-10 | 1995-03-07 | The Du Pont Merck Pharmaceutical Company | Imidazole 5-position substituted angiotensin II antagonists |
US6071931A (en) * | 1995-10-06 | 2000-06-06 | Novartis Ag | AT1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
CA2238975A1 (en) * | 1995-12-12 | 1997-06-19 | Merck & Co., Inc. | New use for losartan |
-
1997
- 1997-09-30 IT IT97RM000586A patent/IT1295405B1/it active IP Right Grant
-
1998
- 1998-09-30 DK DK98946713T patent/DK1019048T3/da active
- 1998-09-30 EP EP98946713A patent/EP1019048B1/en not_active Expired - Lifetime
- 1998-09-30 JP JP2000513573A patent/JP2001517698A/ja active Pending
- 1998-09-30 DE DE1998621252 patent/DE69821252T2/de not_active Expired - Lifetime
- 1998-09-30 AT AT98946713T patent/ATE258051T1/de active
- 1998-09-30 AU AU93666/98A patent/AU754852B2/en not_active Ceased
- 1998-09-30 CA CA002303217A patent/CA2303217C/en not_active Expired - Fee Related
- 1998-09-30 WO PCT/IT1998/000259 patent/WO1999016437A1/en active IP Right Grant
- 1998-09-30 ES ES98946713T patent/ES2213296T3/es not_active Expired - Lifetime
- 1998-09-30 PT PT98946713T patent/PT1019048E/pt unknown
-
2002
- 2002-02-19 US US10/076,396 patent/US6576652B2/en not_active Expired - Fee Related